Hepatitis C virus: virology and life cycle
- PMID: 23593605
- PMCID: PMC3622851
- DOI: 10.3350/cmh.2013.19.1.17
Hepatitis C virus: virology and life cycle
Abstract
Hepatitis C virus (HCV) is a positive sense, single-stranded RNA virus in the Flaviviridae family. It causes acute hepatitis with a high propensity for chronic infection. Chronic HCV infection can progress to severe liver disease including cirrhosis and hepatocellular carcinoma. In the last decade, our basic understanding of HCV virology and life cycle has advanced greatly with the development of HCV cell culture and replication systems. Our ability to treat HCV infection has also been improved with the combined use of interferon, ribavirin and small molecule inhibitors of the virally encoded NS3/4A protease, although better therapeutic options are needed with greater antiviral efficacy and less toxicity. In this article, we review various aspects of HCV life cycle including viral attachment, entry, fusion, viral RNA translation, posttranslational processing, HCV replication, viral assembly and release. Each of these steps provides potential targets for novel antiviral therapeutics to cure HCV infection and prevent the adverse consequences of progressive liver disease.
Keywords: Hepatitis C virus; Life cycle; Virology.
Conflict of interest statement
The authors have no conflicts to disclose.
Figures
Similar articles
-
Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.J Virol. 2015 May;89(10):5362-70. doi: 10.1128/JVI.03188-14. Epub 2015 Mar 4. J Virol. 2015. PMID: 25740995 Free PMC article.
-
Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.J Virol. 2014 Sep;88(18):10584-97. doi: 10.1128/JVI.01402-14. Epub 2014 Jul 2. J Virol. 2014. PMID: 24990994 Free PMC article.
-
Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites.Gastroenterology. 2017 Mar;152(4):895-907.e14. doi: 10.1053/j.gastro.2016.11.047. Epub 2016 Dec 5. Gastroenterology. 2017. PMID: 27932311
-
The hepatitis C virus life cycle as a target for new antiviral therapies.Gastroenterology. 2007 May;132(5):1979-98. doi: 10.1053/j.gastro.2007.03.116. Gastroenterology. 2007. PMID: 17484890 Review.
-
Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.Antivir Ther. 1998;3(Suppl 3):71-81. Antivir Ther. 1998. PMID: 10726057 Review.
Cited by
-
Hepatitis C Viral Infection in Children: Updated Review.Pediatr Gastroenterol Hepatol Nutr. 2016 Jun;19(2):83-95. doi: 10.5223/pghn.2016.19.2.83. Epub 2016 Jun 28. Pediatr Gastroenterol Hepatol Nutr. 2016. PMID: 27437184 Free PMC article. Review.
-
CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections.Int J Mol Sci. 2023 Dec 26;25(1):334. doi: 10.3390/ijms25010334. Int J Mol Sci. 2023. PMID: 38203503 Free PMC article. Review.
-
Role of the Guanine Nucleotide Exchange Factor GBF1 in the Replication of RNA Viruses.Viruses. 2020 Jun 24;12(6):682. doi: 10.3390/v12060682. Viruses. 2020. PMID: 32599855 Free PMC article. Review.
-
Evaluation of interactions between the hepatitis C virus NS3/4A and sulfonamidobenzamide based molecules using molecular docking, molecular dynamics simulations and binding free energy calculations.J Comput Aided Mol Des. 2023 Jan;37(1):53-65. doi: 10.1007/s10822-022-00490-1. Epub 2022 Nov 25. J Comput Aided Mol Des. 2023. PMID: 36427108 Free PMC article.
-
Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication.Virulence. 2022 Dec;13(1):324-341. doi: 10.1080/21505594.2022.2029328. Virulence. 2022. PMID: 35132924 Free PMC article. Review.
References
-
- Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244:359–362. - PubMed
-
- Bartenschlager R, Penin F, Lohmann V, Andre P. Assembly of infectious hepatitis C virus particles. Trends Microbiol. 2011;19:95–103. - PubMed
-
- Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis. 2000;20:17–35. - PubMed
-
- National Institutes of Health. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002. Hepatology. 2002;36(Suppl 1):S3–S20. - PubMed
-
- McHutchison JG, Everson GT, Gordon SC, Jacobson IM, Sulkowski M, Kauffman R, et al. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N Engl J Med. 2009;360:1827–1838. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources